Introduction
The epidural administration of sustained release formulations of local anesthetics is a promising new approach for the management of chronic pain. Anesthetics injected into the epidural space diffuse across the nerve sheaths surrounding the dorsal roots thereby gaining access to the underlying sensory nerve fibers. Clinical studies have demonstrated that the epidural administration of hydrophobic suspensions of n-butyl-p-aminobenzoate (BAB), a butyl ester of aminobenzoic acid, produces long duration analgesia (>30 days) in patients suffering from chronic pain (Shulman, et al., 1990; Korsten, et al., 1991; Shulman, et al., 1998) . This long lasting anesthesia is believed to result from the slow sustained release of BAB from the suspension onto the dorsal root. An important component of this slow release mechanism is the physiochemical properties of BAB, which has a low pKa and water solubility and a high partition coefficient resulting in an overall poor distribution in aqueous solutions (Grouls et al., 1991) . The pain relief produced by BAB is not associated with any significant loss in motor function suggesting that BAB may specifically target the pain sensing C-fibers of the dorsal root (Korsten, et al., 1991; McCarthy, et al., 2002; Shulman, et al., 1998) .
Although the long-duration anesthesia produced by epidural BAB is well documented, the underlying mechanism remains unclear. BAB is an inhibitor of the sodium, calcium, and delayed rectifier potassium currents of DRG neurons ( Van den Berg, et al., 1996; Beekwilder, et al., 2003; Beekwilder et al., 2005) suggesting that the reduced electrical excitability of dorsal root pain fibers is the most likely mechanism of BAB anesthesia ( Van den Berg, et al., 1995) . Electrophysiological characterization of small DRG neurons has identified three broad classifications of voltage-gated K current expressed in these cells: a fast-inactivating (τ ≈ 10 ms) 4-aminopyridine (4-AP) sensitive A-type current (I A ), a slowly inactivating (τ ≈ 100 ms) current, and a tetraethylammonium (TEA) sensitive sustained current (Kostyuk, et al., 1981; Safronov, et al., 1996; Gold, et al., 1996; Christian, et al., 1994; Fedulova, et al., 1998; Yoshimura and de Groat, 1999; Sculptoreanu, et al., 2004) . Studies of the voltage dependence, gating kinetics, and pharmacology have provided insight into the properties of the different components of DRG K current but have not yet identified the channels that underlie these currents. Immunochemical studies suggest that numerous voltage-gated K channels (Kv) are expressed in DRG neurons (Kv1, Kv2) (Ishikawa, et al., 1999) . This is in agreement with the presence of RNA transcripts encoding for Kv1, Kv2, and Kv4 subunits in the DRG (Kim, et al., 2002; Park, et al., 2003; Yang, et al., 2004) . The data indicate that multiple Kv channels contribute to the K current important for setting the resting membrane potential and for repolarizing DRG neurons following an action potential.
In this study, we investigated the effects of BAB on the rapidly inactivating A-type K current (I A ) of small DRG neurons. The voltage-dependent gating and pharmacology of the endogenous K currents were similar to that of Kv4 channels, suggesting that these channels may contribute to the A-type current expressed in DRG neurons. BAB was found to be a potent inhibitor of both the DRG I A and Kv4 were continuously applied using a perfusion pipette positioned approximately 100 µm from the cell. BAB was dissolved in ethanol resulting in bath concentrations of ethanol of <1 %, which was included in drugfree control solutions. This concentration of ethanol had no discernable effect on Kv4 current. The bath temperature was maintained at room temperature (22°C) using a Medical Systems TC-202 temperature controller.
Site-directed mutagenesis
Site-directed mutations of the Kv4.2 channel (accession no. NM031730.1) were made using the QuickChange mutagenesis kit (Stratagene Inc., La Jolla, CA) according to the supplier's instructions. 
GAAGTTAGACACGATCGTAGGCACGGGTAGCGCG

Reverse transcription (RT) PCR
The total RNA of the rat DRG was isolated using RNaqueous-4PCR (Ambion, Austin, TX) according the suppliers instructions. The extracted RNA (0.1 µg) was used as a template for RT-PCR reactions (SuperScript One-Step RT-PCR, Invitrogen, Carlsbad, CA) using gene-specific primers for Kv4 channels (Kv4.1: 5'-CGGACAAATGCTGTGCGTTAG-3', 5'-TAGGGGAGGAAGGTTGACTTTCAT-3'; Kv4.2: 5'-GACGTGAGGGGACAGAGAAC-3' , 5'-CCCCACTTCTTCACCTCAGA-3'; Kv4.3: 5'-TGACAACACTGGGGTATGGA-3', 5'-AACAGGGGATCATCCACAAG-3'). cDNA was synthesized by incubating the reaction mixture at 50 o C for 30 minutes prior to PCR amplification. The cDNA was then denatured at 94 o C for 2 minutes, followed by 35 cycles at 94 o C for 15 s, 55 o C for 30 s, and 72 o C for 15 s. The amplified products were resolved on 2% agarose gels containing ethidium bromide (0.5 µg/ml).
The specificity of the PCR reactions was evaluated by omitting the reverse transcriptase from the reaction mixture, which consistently eliminated cDNA amplification. The amplified cDNA bands were excised from the agarose gels (Qiaquick extraction kit, Qiagen, Valencia, CA) and sequenced (Nucleic Acid Facility, Jefferson Medical College). The predicted size of the cDNA amplicons and the sequences were consistent with those previously published for Kv4 channels.
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Results
Characterization of the DRG A-type (I A ) K current
Small DRG neurons (≈20 µm) typically display a variable combination of rapidly inactivating A-type (I A ), slowly inactivating, and sustained components of K current (Kostyuk, et al., 1981) . Figure 1A shows the whole-cell current of a DRG neuron expressing all three of these currents. External application of 10 mM tetraethylammonium (TEA) selectively reduced the current near the end of the depolarizing pulse consistent with the preferential inhibition of the delayed rectifier K current in these cells (Akins and McCleskey, 1993; Christian, et al., 1994; Gold, et al., 1996) . Increasing the concentration to TEA from 10 to 20 mM resulted in a small additional reduction in the residual current and no change in the peak amplitude (data not shown). At +20 mV, the decay of the current measured in the presence of TEA was found to be biexponential with fast and slow time constants of 24.7 ± 2.2 ms and 128.9 ± 17.2 ms respectively with the rapid component accounting for 39.3 ± 0.03 % of the current under these conditions (n=18). By contrast, Figure 1B shows the current of a DRG neuron predominately expressing the slowly inactivating and sustained components. In these cells, TEA produced a nearly equivalent reduction in the amplitude of the peak and sustained currents. A-type current was frequently detected in these cells but was difficult to study because of the small amplitude and functional overlap with TEAresistant K currents expressed in these neurons. Figure 1C shows a DRG neuron expressing a large component of rapidly inactivating A-type current (I A ). The I A component was relatively insensitive to TEA but potently inhibited by 5 mM 4-aminopyridine (4-AP), which is an effective inhibitor of A-type K current (Thompson, 1982; Gustafsson, et al., 1982) .
To further investigate the properties of the DRG I A we selected cells expressing a prominent component of A-type current similar to that shown in Figure 2A . The voltage-dependent activation of the I A component was determined by measuring the peak current amplitude elicited by depolarizing test pulses. The conductance at each voltage was calculated, normalized to the conductance determined at +40 mV, and plotted versus the test voltage ( Figure 2B ). The DRG I A began to activate at voltages more depolarized than -60 mV, suggesting that the channels underlying this current may be active near the resting membrane potential (-55 mV) of these neurons (Christian, et al., 1994; Sculptoreanu, et al., 2004; Wang et al., 1997) . The steady-state availability was determined from conditioning pulses between -120 and 0 mV and plotted versus voltage ( Figure 2B ). The smooth curves are fits to a Boltzmann function with a midpoint of -74 mV. The recovery from inactivation was determined by applying a depolarizing conditioning pulse to inactivate the channels before measuring the recovery time course at -90 mV. The smooth curve is a fit to an exponential function with a time constant of 107.6 ± 7.1 ms (n=4), consistent with the rapid recovery of I A at hyperpolarized voltages.
This article has not been copyedited and formatted. The final version may differ from this version. (Figure 1 ). An important distinguishing feature is the time course of recovery from inactivation of Kv1.4, which is slow (τ = 2 -4 s) by comparison to what we observed for the DRG I A (τ = 107 ms). Kv3 channels are inhibited by submillimolar concentrations of externally applied TEA (Coetzee, et al., 1999) , which is inconsistent with our finding that the I A component is not appreciably inhibited by comparatively high concentrations (10-20 mM) of this blocker (Figure 1 ). By contrast, Kv4 channels are relatively insensitive to TEA, inhibited by 4-AP, display subthreshold activation, and rapidly recovery from inactivation at hyperpolarized voltages (Jerng, et al., 2004) , properties that are similar to what we observed for the DRG I A (Figure 1 ).
We directly compared the biophysical properties of the DRG I A with those of heterologously expressed Kv4 channels. Figure 3A shows the whole-cell K current of a tsA201 cell expressing Kv4.2.
The K conductance at each voltage was determined from the peak current amplitude, normalized to the conductance measured at +40 mV, and plotted versus the test potential ( Figure 3B ). The threshold for Table 1 ). The recovery from inactivation was determined by applying a depolarizing prepulses to inactivate the channels before measuring the recovery time course at -100 mV. The recovery from inactivation was well fitted with an exponential function with a time constant of 82.1 ± 4.2 ms (n=4). At +20 mV, the decay of the Kv4.2 current was biexponential with fast and slow time constants of 13.4 ± 1.5 ms and 87.8 ± 4.6 ms respectively (n=5). With the exception of a depolarizing shift in the midpoint of inactivation, the steady-state properties of the heterologously expressed Kv4.3 channel were similar to those of Kv4.2 (Table 1) . Despite some differences in the voltage dependence, the gating of the DRG I A component resembles that of heterologously expressed Kv4 channels suggesting that these channels may contribute to the rapidly inactivating K current in these neurons.
To further investigate the contribution of Kv4 channels to the DRG K current, we used reversetranscription (RT) PCR to determine if the RNA transcripts encoding for the Kv4 channels was present in the rat DRG. A single band corresponding to non-conserved regions of the Kv4.1, Kv4.2, and Kv4.3 subunits was amplified from DRG RNA (Figure 4 , RT+). No bands were detected when reverse transcriptase was omitted (RT-) from the reaction mixture confirming that DNA amplification is dependent on the transcription of RNA. The RT+ bands were sequenced and found to be identical to the published cDNA sequences of the respective Kv4 subunits. The presence of transcripts encoding for Kv4 channel subunits in the rat DRG further supports the conclusion that Kv4 channels contribute to the A-type current of these neurons.
BAB inhibition of the DRG I A and Kv4 channels
We have previously shown that BAB inhibits the delayed rectifier current of DRG neurons with an IC 50 of 228 µM (Beekwilder, et al., 2003) . Additional components of delayed rectifier current were observed in these small DRG neurons but these currents were inhibited at comparatively high concentrations of BAB (>500 µM). However, recent work indicated that DRG neurons displaying a prominent I A component were highly sensitive to BAB suggesting that the channels underlying the Atype current may be potently inhibited by the drug. Figure 5A shows that BAB (1 µM) significantly reduced the I A component of DRG K current 12.6 ± 0.5% by comparison to drug-free controls (paired t test, p<0.05, n=4). Because of the low concentration of BAB that was applied (1 µM), the observed reduction in current amplitude is unlikely to result from the inhibition of the sustained component of DRG K current (Beekwilder, et al., 2003) . Rather the data suggest that at low concentrations, BAB preferentially inhibited the rapidly inactivating components of the current. Unfortunately, an accurate assessment and the concentration dependent inhibition of I A was complicated by the variable expression of this component of current in small DRG neurons and the BAB inhibition of the sustained K current when applying higher concentrations of the drug.
We therefore further investigated the mechanism of BAB inhibition using heterologously expressed Kv4 channels. BAB (0.04 -40 µM) reduced the amplitude of the Kv4.2 current in a concentrationdependent fashion ( Figure 5C ). The smooth curve is a fit to a single-site model with a K D of 59 ± 11 nM and steady-state inhibition of 35 ± 0.5% (n=9). Despite applying high concentrations, BAB only partially inhibited the current suggesting that Kv4.2 channels may not be completely blocked when the binding site is fully occupied. The BAB (1 µM) inhibition of Kv4.3 (34.2 ± 4.0 %, n=4) is not significantly different from that of Kv4.2 (30.7 ± 0.04 %, n=5) suggesting that the high-affinity inhibition may be similar for members of the Kv4 family.
We also examined the effects of BAB on Kv4.2 gating ( Figure 6 ). BAB (1 µM) caused a slight (-3 mV) hyperpolarizing shift in the midpoint of steady-state inactivation but did not alter the threshold of activation or the recovery from inactivation ( Figures 6A and 6B ). The time course of the current decay at +20 mV was fitted with the sum of two exponentials with time constants of 11.6 ± 1.0 ms and 66.0 ± 3.4 ms (n=5), which was only slightly different from that of drug-free controls (τ f = 13.4 ms, τ s = 82.8 ms).
Despite reducing the current amplitude by ≈30%, BAB did not appear to substantially alter Kv4.2 gating.
contributes to BAB binding
The S6 membrane-spanning segment of voltage-gated K channels forms the cytoplasmic entrance of the channel and includes amino acids important for the binding of pore blockers (Lopez, et al., 1994; Aiyar, et al., 1994; Shieh and Kirsch, 1994; Yeola, et al., 1996; Decher, et al., 2004) . Figure 7A shows that the primary amino acid sequence of the S6 segment is highly conserved among members of the Kv4 subfamily. Also shown is the helical wheel projection of the S6 segment of Kv4.2, indicating that several conserved hydrophobic amino acids (V397, L400, V404) are aligned along the same face of the proposed α-helix ( Figure 7B ). V397 and L400 are located near the middle of the S6 segment just proximal to the conserved PVP motif, which is believed to induce a bend in the S6 α-helix (Holmgren, et al., 1998; Del Camino, et al., 2000) . V397, L400, and V404 are believed to line the cytoplasmic entrance of the Kv4 pore and are therefore well positioned to contribute to BAB binding.
To investigate the role of the S6 segment in BAB binding we substituted polar threonine residues at positions 397 (V397T), 400 (L400T), and 404 (V404T). Figure 8 shows the currents of the S6 mutants before and after application of BAB (0.01 -100 µM). In the absence of drug, the decay of the currents were fitted by the sum of two exponentials with fast (τ F ) and slow (τ S ) time constants of 11.8 ± 0.8 ms and 98.3 ± 2.9 ms for V397 (n=6) and 17.3 ± 0.8 ms and 80.5 ± 2.5 ms for L400T (n=5). The inactivation kinetics of the S6 mutants was not substantially different from that of the wild-type channel (τ F = 13.4 ms, τ S = 82.8 ms). The midpoints and voltage sensitivity of activation and steady-state inactivation were not altered by the V397T and L400T mutations ( Table 1 ), indicating that substituting polar threonines at these positions does not alter Kv4.2 gating. The V404T mutation caused a -17 mV shift in steady-state inactivation but otherwise did not alter the midpoint of activation or the kinetics of the current.
The peak currents of the S6 mutants measured in the presence of BAB (0.01 -100 µM) were normalized to drug-free controls and plotted versus the concentration ( Figure 8D ). The V397T (K D = 26.8 ± 6.0 µM, n = 12), L400T (K D = 5.4 ± 3.5 µM, n = 3), and V404T (K D = 0.4 ± 0.2 µM, n = 10) mutations differentially affected the BAB inhibition of the channel. Although the V397T and L400T mutations did not substantially alter Kv4.2 gating (Table 1) , these mutations significantly weakened BAB binding to the channels (Table 2 ). This contrasts with V404T, which produced a comparatively modest increase in the K D and a substantial hyperpolarizing shift in steady-state inactivation.
Discussion
BAB is a long-lasting anesthetic that is believed to act by inhibiting ion channels of DRG nociceptors.
In this study, we examined the effects of BAB on the rapidly inactivating A-type K current (I A ) of acutely dissociated rat DRG neurons. We restricted our studies to small DRG neurons (<20 µm), which are believed to represent the cell bodies of unmyelinated nerve fibers (Harper and Lawson, 1985) . These neurons express a variable component of A-type K current that was found to be insensitive to TEA (20 mM) but blocked by 4-AP (5 mM). The I A component activated at voltages near the resting membrane potential of DRG neurons (-55 mV) and displayed rapid inactivation (Figure 2) . The pharmacology and gating properties of the DRG I A were found to be similar to those of heterologously expressed Kv4 channels (Table 1) . RT-PCR was used to establish that the messages encoding for the Kv4 channel subunits (Kv4.1-Kv4.3) are present in the rat DRG (Figure 4 ). Direct comparison of the gating properties indicated that the native I A component activated at more depolarized voltages and recovered from inactivation slowly by comparison to Kv4 channels. We believe that some of these differences may be related to the overlap of the A-type current with slowly inactivating and sustained components of K current expressed in these neurons (Beekwilder et al., 2003) . In addition, Kv4 channels are regulated by several auxiliary proteins (Nadal, et al., 2001; Nadal, et al., 2003; An, et al., 2000) that may be present in the native DRG neurons but absence in our heterologous expression system. Despites these differences, our data support the conclusion that Kv4 channels, either as homo-or heteromultimers, contribute to the rapidly inactivating A-type K current expressed in small DRG neurons. This conclusion is in good agreement with recent studies of DRG A-type K current (Fedulova, et al., 1998; Sculptoreanu, et al., 2004) .
BAB was found to be a potent inhibitor of both the DRG I A and Kv4.2 current ( Figure 5 ).
Unfortunately, a detailed analysis of the properties of the BAB inhibition of the native current was complicated by the variable expression of I A in small DRG neurons and difficulties isolating this component from the sustained K current expressed in these cells. Heterologously expressed Kv4 channels were therefore used to further investigate the mechanism of BAB inhibition. Kv4.2 channels were inhibited by BAB in a concentration-dependent fashion reaching a maximal inhibition of 35 ± 0.5 % at concentrations >1 µM ( Figure 5C To further investigate the mechanism of BAB inhibition, we mutated amino acids of the membranespanning S6 segment of Kv4.2, which is known to form the cytoplasmic entrance of K channels and contribute to the binding of pore blocking drugs (Lopez, et al., 1994; Aiyar, et al., 1994; Shieh and Kirsch, 1994; Yeola, et al., 1996; Franqueza, et al., 1997; Jerng, et al., 1999; Caballero, et al., 2003; Decher, et al., 2004) . V397, L400, and V404 are highly conserved in Kv4 channels and are aligned along a common face of the S6 α-helix (Figure 7) . Residues equivalent to L400 in Kv2.1 and Kv3.1 channels contribute to the binding of internally applied TEA (Aiyar, et al., 1994; Shieh and Kirsch, 1994) . In Shaker and Kv1.5 channels, the threonine at position 397 is an important determinant of alky-TEA and quinidine binding (Choi, et al., 1993; Yeola, et al., 1996) . Mutations at position 404 (V404I) weaken the local anesthetic and 4-aminopyridine block of Kv4 channels (Jerng, et al., 1999; Caballero, et al., 2003) .
Substituting polar threonine at positions 397 and 400 significantly weakened (V397T) or nearly abolished (L400T) the BAB inhibition of the channel ( Figure 8D ). The V397T and L400T mutations did not substantially alter Kv4.2 gating ( Table 1 ), suggesting that threonine substitutions at these positions are well tolerated and do not indirectly alter BAB binding through changes in Kv4.2 gating. BAB is a relatively hydrophobic drug and at physiological pH is uncharged (pKa= 2.6). Replacing hydrophobic valine and leucine residues of the S6 with the more polar threonine significantly increased the K D suggesting that hydrophobic interactions may contribute to BAB binding.
V397 and L400 are situated just proximal to the highly conserved PVP motif of Kv channels ( Figure   7A ), which disrupts hydrogen bonding and induces bends in the S6 α-helix (Del Camino and Yellen, 2001; Del Camino, et al., 2000) . In Shaker, residues positioned upstream of the S6 bend do not appear to participate in the conformational changes linked to channel opening (Webster, et al., 2004; Hackos, et al., 2002) , which is consistent with our data showing that the V397T and L400T mutations do not alter Kv4.2 gating ( Table 1 ). The specific effects of the V393T and L400T mutations on the K D of BAB binding therefore supports the conclusion that these residues, which are proposed to be situated near the narrow region of the pore, are important determinants of drug binding. Our data indicate that BAB shares an overlapping binding site with drugs that inhibit K channels by pore blocking mechanisms (Aiyar, et al., 1994; Choi, et al., 1993; Jerng, et al., 1999) . However, our finding that BAB produced a partial inhibition of Kv4.2 current at high concentrations predicted to fully occupy the binding site suggests that the drug does not act by a simple pore-blocking mechanism, which predicts a complete inhibition of the current at high concentrations. Rather when bound, BAB may not fully inhibit permeation through the channel, resulting in a reduction rather than a complete inhibition of K current.
consistent with the observed effects of the V404T mutation, which produced only a slight reduction in the affinity and steady-state BAB inhibition (Table 2) but induced a substantial hyperpolarizing shift in inactivation (Table 1 ). The data suggests that V404 may not play a direct role in BAB binding, but that polar substitutions at this position may modify Kv4.2 gating or reduce the accessibility of the hydrophobic drug to its binding site situated near the narrow region of the pore.
Kv4 channels encode for a subthreshold activating K current that inactivates at depolarized voltages and rapidly recovers at hyperpolarized potentials (Jerng, et al., 2004) . The A-type currents produced by these channels are important determinants of action potential duration (Bardoni and Belluzzi, 1993 ) and frequency of neuronal firing (Malin and Nerbonne, 2000) . We speculate that the BAB inhibition of DRG Kv4 channels may slow repolarization following an action potential thereby prolonging the refractory period and reducing the firing frequency of DRG neurons. In addition, our data suggest that Kv4 currents may contribute to the resting membrane potential of DRG neurons. The steady-state activation and inactivation of the DRG I A component display considerable overlap between -40 and -60 mV ( Figure 2B ), which is predicted to produce a persistent "window current" at voltages considered to be near the resting membrane potential of DRG neurons (-55 mV) (Christian, et al., 1994; Sculptoreanu, et al., 2004; Wang et al., 1994) . A similar window current is also predicted for the heterologously expressed Kv4.2 channels ( Figure 3B ) (Bahring, et al., 2001) . The BAB inhibition of Kv4 mediated window currents could lead to depolarization of the resting membrane potential. Although this might be expected to increase the excitability of DRG neurons, such changes in resting membrane potential could also indirectly modulate other voltage-gated ion channels expressed in nociceptors. For example, small DRG neurons express a unique combination of tetrodotoxin (TTX) sensitive and TTX resistant Na currents that inactivate between -100 and -30 mV (Wood, et al., 2002) . Depolarization of the resting membrane potential may reduce the steady-state availability of the Na channels that underlie the rapid upstroke of the DRG action potential ( Van den Berg, et al., 1995; Van den Berg, et al., 1996) . We speculate that both the direct BAB inhibition of Kv4 and Kv1.1 channels (Beekwilder, et al., 2003) and the enhanced state-dependent binding of BAB to voltage-gated Na channels ( Van den Berg, et al., 1996) may contribute to the long duration anesthesia produced by the epidural administration of BAB.
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The conductance (G) was normalized to that determined at +40 mV (G o ) and plotted versus the test voltage. The smooth curves are fits to a 4 th -order Boltzmann function (
with an apparent threshold (V m ) and slope factor (k) of -60.3 ± 10.1 mV and 29.6 ± 5.8 mV (n=7). Also plotted is the steady-state inactivation determined by applying 900 ms prepulses to voltages between -120 and 0 mV. A standard test pulse (20 mV/400 ms) was used to assess availability. The test currents were normalized to that measured after prepulsing to -120 mV and plotted versus voltage. Noninactivating current was removed by subtracting the persistent current measured after prepulsing to 0 mV. The smooth curves are fits to a Boltzmann function [h ∞ = 1/(1+exp(V-V 0.5 )/k)] with midpoint (V 0.5 ) and slope factor (k) of -74.0 ± 1.1 mV and 14.0 ± 1.0 mV (n=6). C. Recovery from inactivation was determined by applying a depolarizing conditioning pulse (20 mV/400 ms) before returning the voltage to -90 mV for a variable duration (0-1000 ms). A standard test pulse (20 mV/400 ms) was used to monitor the recovery of the channels. The test currents were normalized to that measured after full recovery (-90 mV/1000 ms) and plotted versus the recovery interval. The smooth curve is a fit to an exponential function with time constant and residual non-inactivating current of 107.6 ± 7.1 ms and 0.21 ± 0.03 respectively (n=4). Boltzmann function with an apparent threshold (V m ) and slope factor (k) of -39.2 ± 2.3 mV and 20.7 ± 1.3 mV (n=5). Also plotted is the steady-state inactivation determined by applying 900 ms prepulses to voltages between -95 and 0 mV before assaying availability using a standard test pulse (0 mV/200 ms).
The test currents were normalized to those measured at -95 mV and plotted versus prepulse potential.
The smooth curve is a fit of the data to a Boltzmann function with V 0.5 and k of -63.4 ± 0.1 mV and 4.6 ± 0.1 mV (n=4) respectively (Table 1 ). The residual non-inactivating component of Kv4.2 current in these experiments was 2.6 ± 0.3%. C. The recovery from inactivation of Kv4.2 was measured by applying a depolarizing prepulse (+10 mV/400 ms) to inactivate the channels before applying a variable duration (1-600 ms) hyperpolarization to -100 mV. The fractional recovery at various times was assessed using a standard test pulse (+10 mV/75 ms). The recovery time course was exponential with a time constant of 82.1 ± 4.2 ms (n=4). increments. The normalized conductance was calculated as described previously (Figure 2 ) and plotted versus the voltage. The smooth curves are fits to a 4 th -order Boltzmann function with V m and k values of -39.2 ± 2.3 mV and 20.7 ± 1.3 mV for controls (n=5) and -40.3 ± 1.6 mV and 21.1 ± 0.9 mV after application of BAB (n=3). Also plotted is the steady-state inactivation measured by applying 900 ms conditioning pulses to voltages between -95 and -40 mV before assessing the availability using a standard test pulse (20 mV/200 ms). The currents were normalized to those measured at -95 mV and plotted versus the test potential. The smooth curve is a fit to a Boltzmann function with a midpoint and slope factor of -63.4 ± 0.1 mV and 4.6 ± 0.1 mV for controls (n=5) and -67.2 ± 0.1 mV and 5.1 ± 0.1 mV after BAB (n=5). B. Recovery was measured by depolarizing to +10 mV for 400 ms before returning to -100 mV for a variable interval (1-600 ms). Test pulses (10 mV/200 ms) applied at the end of the recovery interval were used to assess the recovery time course. The smooth curves are fits to an exponential function with recovery time constants of 84.9 ± 3.6 ms for control (n=5) and 76.2 ± 2.6 ms after application of BAB (n=4). Table 2 . The dotted line is the fitted curve for the wild-type Kv4.2 replotted from Figure 5C .
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